| By PR Newswire | Article Rating: |
|
| November 25, 2009 11:42 AM EST | Reads: |
395 |
SALT LAKE CITY, Nov. 25 /PRNewswire/ -- dazzlesmile, llc www.dazzlesmile.com and Optimal Health Science, LLC www.optimalhealthscience.com have filed a 67-page federal lawsuit against Epic Advertising AKA AzoogleAds AKA azoogle.com, Inc., Jesse Willms, Farend Services Limited, and AtLast Fulfillment. The 13-count Complaint, filed with the United States District Court for the District of Utah, alleges massive national consumer fraud, counterfeiting of dazzlesmile(TM) branded teeth whitening products, violations of the Racketeering Influenced and Corrupt Organizations (RICO) Act, trademark and trade name infringement, conspiracy, and cyber piracy. Google, Yahoo! and Microsoft are also named as defendants for vicarious infringement.
The federal action follows efforts by dazzlesmile(TM) to get Epic, Farend and others to cease and desist using the dazzlesmile(TM) trademark and name to scam thousands of consumers. But consumers are still being tricked into signing up for "free trials" for teeth whitening products, only to discover later that they signed up for additional automatic shipments and additional automatic charges to their credit or debit cards. The Defendants are alleged to have created a confusing web of disinformation that makes canceling or returning products difficult, if not impossible. The unscrupulous tactics have smeared the teeth whitening industry over the past few months and deflected much of the negative attention onto the legitimate operation of dazzlesmile(TM) through the use of infringing advertisements and counterfeit products. dazzlesmile(TM) intends to vigorously assert its rights to protect the legitimate dazzlesmile trade name, mitigate damage to the company's goodwill, and assist defrauded consumers.
dazzlesmile(TM) has been marketed in the US since 2004 as a consumer "on the go" teeth whitening system, consisting of proprietary and patent-licensed mints, toothpaste and mouth wash. dazzlesmile(TM) products consist, in part, of FDA regulated over-the-counter (OTC) ingredients and are manufactured in an FDA approved facility. dazzlesmile(TM) also conforms to FDA prescribed package labeling, and Federal Trade Commission (FTC) requirements for efficacy claims.
A copy of the Complaint can be found at: www.dazzlesmile.com/epicadvertisingcomplaint.pdf
SOURCE dazzlesmile, llc
Published November 25, 2009 Reads 395
Copyright © 2009 Ulitzer, Inc. — All Rights Reserved.
Syndicated stories and blog feeds, all rights reserved by the author.
More Stories By PR Newswire
Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
- Web Hosting, Data Centres, Technology and Cosmetic Surgery
- IBS America, Inc. Generates Buzz at a Successful Lotusphere 2010 in Orlando
- Free PocketCPR iPhone Training App Available for February Heart Month from ZOLL
- Shire Implements ValGenesis Software Solution to Manage the Validation Process Electronically
- The MAC AIDS Fund, the DC Department of Health, the Female Health Company, Washington AIDS Partnership, and CVS/pharmacy Launch Innovative Partnership to Provide Access to Female Condoms in Washington, D.C.
- Twenty-Five Years of HIV Blood Testing Helped to Positively Transform Global Health Crisis
- FDA Issues Consumer Alert on HAPPYTOT Stage 4 and Some HAPPYBABY Stage 1 & Stage 2 Baby Foods
- Thoratec Reports a 19 Percent Increase in Annual Revenues as Cardiovascular Division Revenues Increase 30 Percent in 2009
- Information Update: Rolaids Antacid Tablets Packaged in Bottles Recalled Due to Possible Health Risks
- FDA Consumer Health Information - FDA's MedWatch Safety Alerts: January 2010
- Natural Chelation Alternative Offers New, Non-Invasive Approach to Autism Spectrum Disorder Treatment
- Sanofi-aventis Delivers Double-Digit EPS(1) Growth in 2009 as the Transformation Program Progresses
- T-Systems Creates Innovative Managed Service Based on Cisco WAAS and NetQoS
- Web Hosting, Data Centres, Technology and Cosmetic Surgery
- Biotech Closes the Year on an Upswing
- IBS America, Inc. Generates Buzz at a Successful Lotusphere 2010 in Orlando
- Seapine Software Helps Ziosoft Manage System Requirements Across Two Continents to Meet Strict FDA and Worldwide Compliance
- Advisory: Canadians Advised Not to Use "Stiff Nights" or Any Unauthorized Product Promoted for Erectile Dysfunction
- FDA Says "No Way" to Chinese Shrimp Imports: FDA Ignores Its Own Inspection Data and Refuses Chinese Shrimp Exports to the U.S., According to FDAImports.com, LLC
- Free PocketCPR iPhone Training App Available for February Heart Month from ZOLL
- Shire Implements ValGenesis Software Solution to Manage the Validation Process Electronically
- The MAC AIDS Fund, the DC Department of Health, the Female Health Company, Washington AIDS Partnership, and CVS/pharmacy Launch Innovative Partnership to Provide Access to Female Condoms in Washington, D.C.
- Novartis Launches Schizophrenia Treatment Fanapt in the US, Offering Patients an Attractive Alternative to Existing Medications
- Twenty-Five Years of HIV Blood Testing Helped to Positively Transform Global Health Crisis
- Stock in Focus: Sunwin International Neutraceuticals
- IBM Solutions Help Midmarket Companies Build a More Dynamic Infrastructure
- T-Systems Creates Innovative Managed Service Based on Cisco WAAS and NetQoS
- Introducing Agile: Hidden Benefits (and Some Challenges)
- Hoboken University Medical Center Selects Medsphere's OpenVista Solution to Improve Patient Care, Achieve Meaningful Use
- Web Hosting, Data Centres, Technology and Cosmetic Surgery
- SemBioSys Genetics Inc. Obtains up to $1.5 Million in Funding
- Low Occurrence of Severe Cardiac Side Effects Despite Extensive Prior Doxorubicin Treatment Reported in Pixantrone Pivotal Trial
- FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania
- Biotech Closes the Year on an Upswing
- DataCore Software Partner Far West Technologies Implements Compliance, Virtualization and Business Continuity Solutions for Anaheim Memorial and San Gabriel Valley Medical Centers
- Pixantrone Produces High Rates of Complete Remission in Multiple Relapsed and Refractory Indolent and Aggressive Non-Hodgkin's Lymphoma
























Ulitzer content is offered under Creative Commons "Attribution Non-Commercial No Derivatives" License.
For any reuse or distribution, you must make clear to others the license terms of this work.
The best way to do this is with a link to this web page.
Any of the above conditions can be waived if you get written permission from Ulitzer, Inc., the copyright holder.
Nothing in this license impairs or restricts the author's moral rights.